EASTGATE BIOTECH CORP (ETBI)
Institutional ownership reported to the SEC as of Q4 2024, across 14 quarters.
1
Reporting holders
$1.3K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Associated Banc-Corp | $1.3K | 288,600 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2024 | 1 | $1.3K | 288,600 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $1.3K | 288,600 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $1.3K | 288,600 | 1 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $2.9K | 288,600 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $490 | 288,600 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $634 | 288,600 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $663 | 288,600 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 1 | $865 | 288,600 | 0 | 0 | 0 | 0.0% |
| Q3 2022 | 1 | $1.0K | 288,600 | 0 | 0 | 0 | 0.0% |
| Q2 2022 | 1 | $1.0K | 288,600 | 0 | 0 | 0 | 0.0% |
| Q1 2022 | 1 | $1.0K | 288,600 | 0 | 0 | 0 | 0.0% |
| Q4 2021 | 1 | $1.0K | 288,600 | 1 | 0 | 0 | 0.0% |
| Q4 2020 | 1 | $1.0K | 288,600 | 0 | 0 | 0 | 0.0% |
| Q3 2020 | 1 | $1.0K | 288,600 | 1 | 0 | 0 | 0.0% |